about
The molecular basis of lecithin:cholesterol acyltransferase deficiency syndromes: a comprehensive study of molecular and biochemical findings in 13 unrelated Italian familiesRisk of Kaposi's sarcoma and of other cancers in Italian renal transplant patients.De novo malignancies after organ transplantation: focus on viral infections.Epidemiology of de novo malignancies after solid-organ transplantation: immunosuppression, infection and other risk factors.Incidence of second primary cancer in transplanted patients.Risk of de novo cancers after transplantation: Results from a cohort of 7217 kidney transplant recipients, Italy 1997–2009Risk of Kaposi Sarcoma after Solid-Organ Transplantation: Multicenter Study in 4767 Recipients in Italy, 1970–2006Risk of cancer following immunosuppression in organ transplant recipients and in HIV-positive individuals in southern Europe[Kidney transplant and cancer risk: an epidemiological study in Northern and Central Italy]Immunosuppression and Cancer: A Comparison of Risks in Recipients of Organ Transplants and in HIV-Positive IndividualsKaposi???s Sarcoma in Transplant and HIV-infected Patients: An Epidemiologic Study in Italy and FranceAcquired lecithin:cholesterol acyltransferase deficiency as a major factor in lowering plasma HDL levels in chronic kidney disease[The hemodialysed patient and his/her family caregiver. Comparison of perceptions of the chronic illness]Whole blood selective LDL-apheresis: a comparison of two different adsorbersLong-term follow-up of simultaneous heart and kidney transplantation with single donor allografts: report of nine casesThe Italian Registry for Therapeutic Apheresis. A report from the Apheresis Study Group of the Italian Society of Nephrology[Indications for apheresis in kidney transplant recipients: apheresis in the hyperimmune patient]
P50
Q28259670-05FFBE05-41CF-4FEC-8C0D-F3D28ED0E958Q36616999-14384BDE-FEE5-429E-B4EF-2AFA1D8D1C3CQ38070728-DE241319-00BD-4B9F-81F6-6922BFC3A58FQ41744111-EC0D2105-8980-4384-80A6-2567AD78D2E1Q50780221-A16CA62D-A905-4D36-BFB4-10B1A42A166FQ56334541-A60555F7-F7EC-49C3-AAEB-E2F94A6B2FC4Q56336113-1D532D59-DB7B-435C-BFF7-7AA9F582AF6AQ58281040-53E98C3A-6382-46E1-89F3-373A5A176E10Q58868003-4444076A-6023-464F-98CB-7FBFFC38C90DQ58868009-8F4662FF-2895-4C93-95DE-97A6CBA72BA3Q58868014-55D2F9CD-F686-46C2-9369-199DD3E3398DQ60181971-DE381B37-62BE-409B-BC4F-9E6F2B98332BQ79991776-3C12476E-2200-4A18-9F5D-8E468C3982D9Q80015724-10CFF1E6-FAF0-43A7-A80F-83C41CA37BA8Q80649189-A0879739-8D94-458E-87B0-0CCBF674FCFBQ81725942-4A496A89-8B14-4FED-B107-000CD794368AQ83568646-6259A206-52F9-41A2-BE73-70449AA9EF1E
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
G Busnach
@ast
G Busnach
@en
G Busnach
@es
G Busnach
@nl
G Busnach
@sl
type
label
G Busnach
@ast
G Busnach
@en
G Busnach
@es
G Busnach
@nl
G Busnach
@sl
prefLabel
G Busnach
@ast
G Busnach
@en
G Busnach
@es
G Busnach
@nl
G Busnach
@sl
P106
P31
P496
0000-0002-4013-050X